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ultrasound was the most common imaging procedure both 12 months pre- and 
36 months post-index (31.0%, 54.6%, respectively), followed by abdominal/pelvic 
ultrasound (27.3%, 49.6%, respectively). ConClusions: Approximately one-third of 
women with newly diagnosed uterine fibroids underwent hysterectomy within the 
first year of initial diagnosis. Minimally invasive procedures such as hysteroscopic 
myomectomy were infrequently utilized, despite published evidence showing con-
siderably lower costs and complication rates over hysterectomy.
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objeCtives: While effectiveness of fibrin sealants for controlling bleeding in car-
diac surgery has been demonstrated, there is a paucity of research on other clinical 
outcomes of fibrin sealants. In this retrospective observational study we analyzed 
the clinical outcomes of two different fibrin sealants in a population of patients 
undergoing cardiac surgical procedures. Methods: Data from patients undergoing 
coronary artery bypass grafting (CABG), valve and valvular procedures with CABG 
during the years 2008 - 2012 were extracted from Premier’s Hospital Database. The 
Premier Hospital Database is a comprehensive database containing data from over 6 
million US hospital discharges annually. Only surgeries in which a fibrin sealant was 
utilized were included; all other hemostatic agents were excluded from the study. The 
following clinical outcomes were assessed: major and minor complications, transfu-
sions, surgical revisions for bleeding, operative mortality (hospitalization), OR time 
and hospital and ICU length of stay (LOS). Logistic regression analyses were performed 
on categorical outcome variables and GLM regression analyses were performed on 
continuous outcome variables. Study covariates included: age, primary procedure, 
Charlson Co-morbidity Index (CCI) score, heparin use, protamine use, admission type, 
gender, race, teaching hospital, bed size and region. Results: A total of 2,560 inpa-
tient cardiac procedures using fibrin sealant with synthetic aprotinin (FS-apr) were 
compared to 1,019 procedures using fibrin sealant without aprotinin (FS). Results 
suggested that FS-apr was associated with significantly lower rates of minor compli-
cations (21.1% vs. 27.1%, p = 0.002), Day 1 Transfusions (28.6% vs. 36.8%, p = 0.015) and 
ICU LOS (4.7 days vs 7.1 days, p < 0.0001) as compared to FS. No significant differences 
were found between FS-apr and FS on the other clinical outcomes. ConClusions: 
FS-apr was associated with signficantly lower rates of Day 1 Transfusions, avoidable 
minor complications and lower average ICU LOS as compared to FS.
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objeCtives: Peripheral Blood Transplant (PBT) accounted for three-quarters of 
the Hematopoietic Cell Transplant (HCT) from unrelated donors in the past dec-
ade, which indicates it has largely replaced Bone Marrow Transplant (BMT) as 
the preferred graft source. This shift occurred due to evidence suggesting faster 
neutrophil and platelet engraftment with the former. However, clinical evidence 
favoring PBT for other outcomes is inconclusive. Although meta-analyses have 
compared outcomes for PBT and BMT from related donors, no such analysis has 
been conducted for unrelated donor procedures. Our objective is to conduct a 
meta-analysis comparing the outcomes in patients undergoing allogeneic unre-
lated donor HCT comparing PBTvs.BMT. Methods: We conducted a systematic 
literature search(PUBMED,CANCERLIT and Cochrane databases) identifying rand-
omized trials and retrospective studies comparing outcomes of allogeneic unrelated 
donor PBTvs.BMT. We extracted longitudinal transplant outcomes, including acute 
graft-versus-host disease(GVHD) grade II to IV(aGVHD), chronic GVHD(cGVHD), 
overall-survival(OS), transplant-related mortality(TRM), disease-free survival(DFS) 
and relapse from published Kaplan-Meier curves. We used the inverse variance 
method(Cochrane RevMan5.3.5) to estimate pooled hazard ratios(HRs) and 95% con-
fidence-intervals(CI). HR value< 1.00 for an outcome signified PBT as the favorable 
option compared to BMT. Results: One randomized trial and five retrospective 
studies were included in the analysis. PBT was significantly less favorable than BMT 
on aGVHD [HR(1.30),CI(1.15 to 1.47)] and cGVHD [HR(1.32), CI(1.16 to 1.49)]. We did-
not find statistically significant differences in other outcomes:OS [HR(1.02),CI(0.86 
to 1.21)], DFS [HR(1.00),CI(0.91 to 1.10)], Relapse [HR(1.02,CI (0.78 to 1.34)] and TRM 
[HR(0.98),CI(0.77 to 1.24)]. ConClusions: Although PBT is the predominant mode 
of allogeneic HCT, our meta-analysis found no outcomes for which PBT is favorable 
compared to BMT. The only statistically significant comparisons indicated increased 
hazard of acute and chronic GVHD with PBT. While PBT may offer other clinical 
advantages over BMT that merit weight in clinical decision-making, its failure to 
demonstrate significant improvements in overall survival, disease-free survival 
and transplant-related mortality and increased risk of GVHD calls current clinical 
practice into question.
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patients subjected to PMs implantation, initial or replacement, in our center compared 
with others studies. In the case of ICD implantations, initials or replacements, there 
weren’t any adverse event. The additional hospitalization days and cost attributed 
to these adverse events depends on the nature of adverse event.
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objeCtives: Research on prognostic factors of ventricular arrhythmias inducibility 
in patients with severe reduced LV systolic function being ICD candidates for primary 
prevention of sudden cardiac death has given limited results so far. Aim of our study 
was to examine the relationship of specific echocardiographic markers, beyond LV 
ejection fraction, particularly left ventricular hypertrophy and left ventricular end-
diastolic diameter, with ventricular arrhythmias inducibility during electrophysiologi-
cal study in patients with ischemic cardiomyopathy. Methods: Data were acquired 
from patients with ischemic cardiomyopathy and severe reduced LV systolic function 
who underwent electrophysiological in the context of primary prevention of sud-
den cardiac death. Electrophysiological study protocol included programmed elec-
trical stimulation from right ventricular apex. Results: Of 119 patients included, 
ventricular arrhythmias were induced in 76 (63.9%). Prior echocardiographic study 
revealed 26 (21%) patients with ventricular hypertrophy (defined as interventricular 
septum and posterior wall diastolic thickness > 11mm) and 90 patients (76.3%) with 
dilated left ventricle (defined as LV end-diastolic diameter > 55 mm). 80% of patients 
with left ventricular hypertrophy had ventricular arrhythmias induced compared 
to 59% of patients without ventricular hypertrophy (p< 0.05). However, as regards 
LV end-diastolic diameter, difference between groups was not statistically signifi-
cant (p= 0.92). ConClusions: In populations at high risk for sudden cardiac death, 
such as ischemic cardiomyopathy patients, ventricular hypertrophy is correlated to 
ventricular arrhythmias inducibility and possibly is a risk factor for spontaneous 
malignant arrhythmias.
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objeCtives: To compare QFT-GIT to TST in detection of latent TB infection among 
National Guard general population in Saudi Arabia. Methods: a total of 1369 subjects 
chosen randomly from the catchment areas of PHC centers of national Guard Health 
Affairs in Saudi Arabia. inclusion criteria were Saudi national, age 5 years or more, 
resident of Saudi Arabia and availability during the study. Exclusion criteria included 
age less than 5 years (to avoid the BCG vaccination effect on the results ), present or 
previous active tuberculosis, those already diagnosed of having LTBI &/ or on anti TB 
prophylaxis & all immunocompromised conditions. Blood was drawn and processed 
using QFT-GIT followed by immediate administration of TST solution on subjects fore-
arm. Data were collected and analyzed using SPSS software. Results were compared 
using the chi-square test & kappa coefficient was calculated. Results: both tests 
had a significant overall agreement of 88.8% (k= 0.332; p< 0.001). Negative concordance 
represented 85.2% and positive concordance represented 3.6% . Positive QFT-GIT but 
negative TST was 5.5% of the results while positive TST but negative QFT-GIT was 
5.7% of the results. Concordance was associated significantly with younger ages and 
female gender. Positive results in both tests were significantly associated with older 
ages and male gender only in 15-44 years age group. ConClusions: The overall 
agreement of TST & QFT-GIT among Saudi National Guard general population was 
88.8% for detection of LTBI. In absence of a gold standard, QFT-GIT showed acceptable 
results compared to TST for detecting LTBI in intermediate TB burden country with 
at birth BCG highly vaccinated population.
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objeCtives: To describe treatment patterns and diagnostic pathways for women 
with uterine fibroids up to three years following a new diagnosis. Methods: 
Patients with a new diagnosis of uterine fibroids (ICD-9 code: 218.9) were identi-
fied in the Truven Health MarketScan Research Databases from 2004-2013. The use 
of specific diagnostic and treatment procedures and medications were described 
in the 12 months prior to (pre-index) and in the 12, 24 and 36 months following 
(post-index) the diagnosis (index event). Patients were required to have continuous 
enrollment throughout the pre- and post-index periods. Results: A total of 359,672 
patients met the selection criteria with mean age 46.1 years (SD= 9.3) at first diag-
nosis. Of those, subsets of 244,827 (68.1%) patients and 164,645 (45.8%) patients had 
24 and 36 months of post-index follow-up, respectively. Hysterectomy was the most 
common surgical intervention, increasing from 29.3% in the first 12 months to 35.5% 
in the first 36 months; average time to hysterectomy was 49.7 days. Other surgical 
interventions used within the first 12 months of follow-up included: endometrial 
ablation (5%), curettage (3.6%), and either hysteroscopic myomectomy, laparascopic 
myomectomy, abdominal myometcomy, or uterine emobolization (< 2% each). 13.1% 
of women used hormonal birth control with higher rates among younger women. 
IUDs or Gnrh agonists were used by approximately 1% of women. Transvaginal 
